Norda ASA Stock Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Sales 2021 | 139M 12.65M | Sales 2022 | 128M 11.62M | Capitalization | 204M 18.51M |
---|---|---|---|---|---|
Net income 2021 | 82M 7.45M | Net income 2022 | 100M 9.08M | EV / Sales 2021 | 0.22 x |
Net cash position 2021 | 159M 14.42M | Net cash position 2022 | 257M 23.32M | EV / Sales 2022 | -0.41 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 6.26% |
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-17.60% | 11.52B | |
+39.11% | 3.27B | |
-20.67% | 2.02B | |
-29.30% | 1.44B | |
+11.45% | 1.01B | |
-6.33% | 719M | |
-30.75% | 418M | |
-51.02% | 339M | |
-2.58% | 284M |